Screener
Cullinan Therapeutics, Inc. CGEM Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $3,725 | $841 |
| Accrued expenses and other current liabilities | 36,237 | 36,120 |
| Operating lease liabilities, current | 666 | 780 |
| Total current liabilities | 40,628 | 37,741 |
| Operating lease liabilities, net of current portion | 1,405 | 1,903 |
| Total liabilities | 42,033 | 39,644 |
| Commitments and contingencies (Note 8) | ||
| Stockholders' equity: |
Item 1. Financial Statements.
FAQ
- What is Cullinan Therapeutics, Inc.'s total current liabilities?
- Cullinan Therapeutics, Inc. (CGEM) reported total current liabilities of $40.63M in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Cullinan Therapeutics, Inc.'s total current liabilities increased by 44.8% year-over-year, from $28.06M to $40.63M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s total current liabilities has grown at a 21.4% compound annual growth rate (CAGR), from $14.32M to $37.74M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Cullinan Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude